Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000107

Director acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SAXE JON S Director 2019-01-29 Option exercise +375 $1.50 $563 2,251 D
SAXE JON S Director 2019-01-29 Option exercise +1,000 $1.50 $1,500 3,251 D
Derivatives
SAXE JON S Director 2019-01-29 Option exercise · Stock Option (Right to Buy) −375 0 D
SAXE JON S Director 2019-01-29 Option exercise · Stock Option (Right to Buy) −1,000 0 D
Loading xslF345X03/form4-01302019_040107.xml…